
Letolizumab
CAS No. 1450981-87-9
Letolizumab( —— )
Catalog No. M36807 CAS No. 1450981-87-9
Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 257 | Get Quote |
![]() ![]() |
5MG | 426 | Get Quote |
![]() ![]() |
10MG | 679 | Get Quote |
![]() ![]() |
25MG | 994 | Get Quote |
![]() ![]() |
50MG | 1343 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLetolizumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionLetolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.
-
DescriptionLetolizumab (BMS-986004) is a monoclonal antibody targeting CD40L, which is produced to express mutant IgG1 lacking effector function, including Fc binding and complement fixation. Letolizumab reduces rejection, thromboembolism and prolongs the survival time.
-
In Vitro——
-
In VivoAnimal Model:Rhesus macaques after renal transplantation.Dosage:2, 10 and 20 mg/kg.Administration:Intravenous injection; once a week for 10 weeks.Result:Increased the survival time.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorImmunology/Inflammation related
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1450981-87-9
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Karnell JL, et al. Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond. Adv Drug Deliv Rev. 2019 Feb 15;141:92-103. ?
molnova catalog



related products
-
cis-10-Heptadecenoic...
cis-10-Heptadecenoic acid is a minor constituent of ruminant fats.
-
Aviptadil
Aviptadil (INN) is an analog of vasoactive intestinal polypeptide (VIP) for the treatment of erectile dysfunction.
-
ISX-1
ISX-1 inhibits adipogenesis and promotes osteoblastogenesis. ISX-1 can be used in studies about osteoporosis and osteopenia.